SIREN : 482791100
DIAGNOSTICS 47 is a French company founded 21 years ago, specialized in the sector Analyses, essais et inspections techniques. Based in MARMANDE (47200), this company of category PME shows in 2022 a revenue of 804 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | N/C | N/C | 803 839 € | N/C | N/C |
| Net income | 154 860 € | 88 839 € | 87 402 € | 94 175 € | 65 563 € |
| EBITDA | N/C | N/C | 167 643 € | N/C | N/C |
| Net margin | N/C | N/C | 10.9% | N/C | N/C |
In 2024, DIAGNOSTICS 47 generates positive net income of 155 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 66 k€ -> 155 k€.
154 860 €
The debt ratio (= Financial debt / Equity x 100) stands at 39%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
38.54%
55.0%
52.9%
In 2024, the debt ratio of DIAGNOSTICS 47 (38.54) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of DIAGNOSTICS 47 (55.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2022, the repayment capacity of DIAGNOSTICS 47 (1.62) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 176.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
176.037
In 2024, the liquidity ratio of DIAGNOSTICS 47 (176.04) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2022, the interest coverage of DIAGNOSTICS 47 (0.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (41 transactions). This range of 106 905€ to 994 895€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 41 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare DIAGNOSTICS 47 with other companies in the same sector:
Voir toutes les statistiques du secteur Analyses, essais et inspections techniques
The revenue of DIAGNOSTICS 47 in 2022 is 804 k€.
Yes, DIAGNOSTICS 47 generated a net profit of 155 k€ in 2024.
The headquarters of DIAGNOSTICS 47 is located in MARMANDE (47200), in the department Lot-et-Garonne.
The tax return of DIAGNOSTICS 47 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
DIAGNOSTICS 47 operates in the sector Analyses, essais et inspections techniques (NAF code 71.20B). See the 'Sector positioning' section above to compare the company with its competitors.